SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company has two product lines of fertility control products: ContraPest and Evolve. Its product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions of the rat population. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. Additionally, ContraPest does not cause illness in rats, and, therefore, it does not change behavior or result in bait aversion. ContraPest offers a new tool used in coordination with rodenticides as part of an integrated pest management program. The Company's technology can also be applied to other mammalian species.
Ticker SymbolSNES
Company nameSenestech Inc
IPO dateDec 08, 2016
CEOMr. Joel L. Fruendt
Number of employees23
Security typeOrdinary Share
Fiscal year-endDec 08
Address777 W. Pinnacle Peak Road
CityPHOENIX
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code85027
Phone19287794143
Websitehttps://senestech.com/
Ticker SymbolSNES
IPO dateDec 08, 2016
CEOMr. Joel L. Fruendt
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data